Electrochemical sensor based on α-Fe2O3/rGO core-enhanced carbon interfaces for ultra-sensitive metronidazole detection

In this work, we describe the creation of a new magneto-electrochemical biosensor that detects metronidazole (MTZ), an antibiotic that is frequently used to treat anaerobic bacterial and protozoal infections, with extreme sensitivity. The sensor platform is engineered by integrating α-Fe<sub>2</sub>O<sub>3</sub> magnetic core nanoparticles with reduced graphene oxide (rGO) to fabricate a core-enhanced carbon electrode (α-Fe₂O₃/rGO@CE). The synergistic combination of α-Fe<sub>2</sub>O<sub>3</sub> and rGO significantly enhances the electrocatalytic activity, electron transfer rate, and surface area of the sensing interface. Using X-ray diffraction (XRD), electrochemical impedance spectroscopy (EIS), and scanning electron microscopy (SEM), structural and morphological characterizations were carried out to verify the uniform distribution of spherical α-Fe<sub>2</sub>O<sub>3</sub> nanoparticles (~ 25 nm) anchored on rGO nanosheets. Electrochemical performance was systematically investigated through cyclic voltammetry (CV) and Differential Pulse voltammetry (DPV). When compared to the unmodified Counter Electrode (CE) (-0.65 V against Ag/AgCl), the suggested biosensor showed a notable change in the metronidazole reduction peak to a higher positive potential (-0.4 V vs. Ag/AgCl), suggesting superior catalytic efficiency. With a remarkable limit of identification (LOD) of 2.80 × 10<sup>-6</sup> M and a limit of quantization (LOQ) of 8.0 × 10<sup>-6</sup> M, a broad linear detection range of 8.0 × 10<sup>-6</sup> to 1.0 × 10<sup>-5</sup> M was attained. The sensor was effectively used for the quantitative measurement of metronidazole in medication and in human urine samples (collected from Mangalore Medical Centre with informed consent obtained from the respective patients, ensuring ethical compliance for clinical analysis) due to its exceptional sensitivity, stability, and reproducibility. This study demonstrates how α-FeO₃/rGO hybrid nanomaterials can be used to create effective magneto-electrochemical biosensors for use in clinical and pharmaceutical diagnostic settings.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2025-10-09
DOI
https://doi.org/10.1038/s41598-025-19377-w
Citations
2
Primary Topic
Advanced biosensing and bioanalysis techniques
Type
article
Field-Weighted Citation Impact
1.61

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Electrochemical sensor based on α-Fe2O3/rGO core-enhanced carbon interfaces for ultra-sensitive metronidazole detection

Azath Mubarakali, Abdulrahman Saad Alqahtani, Adarsh Rag S, Asma AlJarullah et al.
2 citations
Scientific Reports
Advanced biosensing and bioanalysis techniques
1.61
article

Electrochemical sensor based on α-Fe2O3/rGO core-enhanced carbon interfaces for ultra-sensitive metronidazole detection

Azath Mubarakali, Abdulrahman Saad Alqahtani, Adarsh Rag S, Asma AlJarullah, Hashim Elshafie, M. Venkatesh, P. Parthasarathy
article en
2 citations

Abstract

In this work, we describe the creation of a new magneto-electrochemical biosensor that detects metronidazole (MTZ), an antibiotic that is frequently used to treat anaerobic bacterial and protozoal infections, with extreme sensitivity. The sensor platform is engineered by integrating α-Fe<sub>2</sub>O<sub>3</sub> magnetic core nanoparticles with reduced graphene oxide (rGO) to fabricate a core-enhanced carbon electrode (α-Fe₂O₃/rGO@CE). The synergistic combination of α-Fe<sub>2</sub>O<sub>3</sub> and rGO significantly enhances the electrocatalytic activity, electron transfer rate, and surface area of the sensing interface. Using X-ray diffraction (XRD), electrochemical impedance spectroscopy (EIS), and scanning electron microscopy (SEM), structural and morphological characterizations were carried out to verify the uniform distribution of spherical α-Fe<sub>2</sub>O<sub>3</sub> nanoparticles (~ 25 nm) anchored on rGO nanosheets. Electrochemical performance was systematically investigated through cyclic voltammetry (CV) and Differential Pulse voltammetry (DPV). When compared to the unmodified Counter Electrode (CE) (-0.65 V against Ag/AgCl), the suggested biosensor showed a notable change in the metronidazole reduction peak to a higher positive potential (-0.4 V vs. Ag/AgCl), suggesting superior catalytic efficiency. With a remarkable limit of identification (LOD) of 2.80 × 10<sup>-6</sup> M and a limit of quantization (LOQ) of 8.0 × 10<sup>-6</sup> M, a broad linear detection range of 8.0 × 10<sup>-6</sup> to 1.0 × 10<sup>-5</sup> M was attained. The sensor was effectively used for the quantitative measurement of metronidazole in medication and in human urine samples (collected from Mangalore Medical Centre with informed consent obtained from the respective patients, ensuring ethical compliance for clinical analysis) due to its exceptional sensitivity, stability, and reproducibility. This study demonstrates how α-FeO₃/rGO hybrid nanomaterials can be used to create effective magneto-electrochemical biosensors for use in clinical and pharmaceutical diagnostic settings.

Scientific ReportsVol. 15(1)
Manipal Academy of Higher Education (IN), CMR University (IN), University of Bisha (SA), King Khalid University (SA)
King Khalid University
Openalex Percentile: Top 14%
Advanced biosensing and bioanalysis techniques
1.61
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.